Key result
Only ~7% of Australian pharmacy home BP devices are validated for pregnancy and cost more.
Why the study?
Automatic blood pressure devices require accuracy validation among pregnant individuals before being recommended, but the availability of such validated devices in Australian pharmacies was unknown.
Cross-Sectional (n=54)
There is a significant lack of validated and affordable automatic blood pressure devices for pregnant women in Australian pharmacies, highlighting a need for better availability and consumer education.
Clinicians should verify pregnancy-specific validation before recommending devices; leaves open the need for wider availability and education.
Blood pressure monitoring is a critical aspect of prenatal care, as hypertension during pregnancy can lead to serious complications such as preeclampsia, eclampsia, and other hypertensive disorders. Automatic blood pressure devices are widely used for home monitoring due to their convenience and ease of use. The use of validated automated blood pressure monitors is recommended by the International Society of Hypertension for home blood pressure measurements, and automatic devices require accuracy validation among people who are pregnant before they are recommended for use in pregnancy. This study evaluated availability of such devices from 18 Australian pharmacies. Only four devices (4/54, 7%) were validated for pregnancy and were more expensive than devices validated for the general population (14/54, 26%) and non-validated devices (40/54, 74%). Additionally, limited labelling and information was available to assist consumers to make informed purchasing decisions about home blood pressure devices for use in pregnancy. Increased availability, clear labelling and consumer education could help ensure use of appropriate blood pressure devices in pregnancy. Automatic blood pressure devices require additional accuracy validation for use in pregnancy. We found only four devices (4/54, 7%) were validated for pregnancy, which were more expensive than non-validated devices. Increased education could help ensure use of appropriate blood pressure devices in pregnancy.
No takes yet. Share an insight, caveat, or question.
Slater et al. (2025) conducted a cross-sectional in Hypertension in pregnancy (n=54). Home blood pressure devices was evaluated on Proportion of devices validated for use in pregnancy. Only 4 of 54 (7%) home blood pressure devices available from Australian pharmacies were validated for use in pregnancy, and these were more expensive than non-validated devices.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: